Lv725
4280 积分 2024-02-29 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
6天前
已完结
Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli
1个月前
已完结
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for Harmonization
2个月前
已完结
Cultivation of the CHO Cell Line in Bioreactors of Various Volumes: Technological Optimization
4个月前
已关闭
Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli
4个月前
已完结
Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
5个月前
已完结
Engineering multi-specific nano-antibodies for cancer immunotherapy
5个月前
已完结
Research trends in the use of nanobodies for cancer therapy
5个月前
已完结
The downstream purification of bispecific antibodies
6个月前
已完结
Efficiently scaled-up production of recombinant human elastin-like polypeptides using multiple optimization strategies
6个月前
已完结
皖公网安备34019202002308
